Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 both as...
Silver Palace Unveiled: A Detective Adventure ARPG in Victorian Aesthetics
The new title features a prosperous metropolis in Victorian aesthetics where players will embark on an adventure with diverse characters and engage in dynamic action-oriented combat. SINGAPORE, May 13, 2025 /PRNewswire/ -- Silver Palace, a fantasy...
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISS Collaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in Space IM8, a new premium supplements brand launched officially on November 18th on IM8health.com...